Skip to content

Heweiyangxue Huacai formula in the treatment of cancer-realted fatigue with non-small cell lung cancer:a randomized controlled trial

Heweiyangxue Huacai Formula in the treatment of cancer-realted fatigue with non-small cell lung cancer:a randomized controlled trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400083694
Enrollment
Unknown
Registered
2024-04-30
Start date
2024-04-30
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-small cell lung cancer

Interventions

Experimental group:Conventional Western medicine treatment + Heweiyangxue Huacai Formula add or subtract
Control group:Conventional Western medicine treatment

Sponsors

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: ?With clear histological or cytological pathology confirmed diagnosis of non-small cell lung cancer; ?Patients who met the TCM diagnostic criteria of lung and Spleen Qi eficiencySyndrome; ?Patients who met the diagnostic criteria of cancer-related fatigue,and NRS score >3;?Eastern Cooperative Cancer Group (ECOG) physical status score 0-2;?Patients who are receiving conventional Western medical treatment;?Age =18 and <80 years old, regardless of gender;

Exclusion criteria

Exclusion criteria: ?Patients who have serious, uncontrolled organic diseases or infections, such as decompensated heart, lung, liver and kidney failure, resulting in inability to tolerate chemotherapy or poor systemic condition, unable to eat; ? Patients who have severe metabolic disorders; ?Pain NRS score =7 points; ?Patients with symptomatic, uncontrollable neurological, mental illness or mental disorder or the Hospital Anxiety and Depression Scale score =8 points;

Design outcomes

Primary

MeasureTime frame
Piper’s Fatigue Scale;

Secondary

MeasureTime frame
FACT-F;ECOG score;EORTC QLQ-C30 score;Lung cancer TCM syndrome score;Cluster of Differentiation;cytokine;5-HT;

Countries

China

Contacts

Public ContactWeiwei Zhang

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine

zww6516@163.com+86 189 3056 8303

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026